Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted therapy for anxiety in life-threatening illness
NCT02427568Phase 2Completed
- Sponsor
- Lykos Therapeutics
- Start
- May 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in anxiety disorder, sponsored by Lykos Therapeutics. Started May 2015; status: completed.
02
Drugs
midomafetamine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT02427568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427568.